GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Amcad Biomed Corp (ROCO:4188) » Definitions » PS Ratio

Amcad Biomed (ROCO:4188) PS Ratio : 14.83 (As of Apr. 25, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Amcad Biomed PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Amcad Biomed's share price is NT$13.45. Amcad Biomed's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was NT$0.91. Hence, Amcad Biomed's PS Ratio for today is 14.83.

Good Sign:

Amcad Biomed Corp stock PS Ratio (=14.62) is close to 2-year low of 14.62.

The historical rank and industry rank for Amcad Biomed's PS Ratio or its related term are showing as below:

ROCO:4188' s PS Ratio Range Over the Past 10 Years
Min: 7.78   Med: 20.22   Max: 10917.88
Current: 14.83

During the past 13 years, Amcad Biomed's highest PS Ratio was 10917.88. The lowest was 7.78. And the median was 20.22.

ROCO:4188's PS Ratio is ranked worse than
89.66% of 803 companies
in the Medical Devices & Instruments industry
Industry Median: 3.07 vs ROCO:4188: 14.83

Amcad Biomed's Revenue per Sharefor the three months ended in Dec. 2024 was NT$0.29. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was NT$0.91.

Warning Sign:

Amcad Biomed Corp revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of Amcad Biomed was -25.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was -16.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was -7.80% per year.

During the past 13 years, Amcad Biomed's highest 3-Year average Revenue per Share Growth Rate was 664.00% per year. The lowest was -54.60% per year. And the median was 3.50% per year.

Back to Basics: PS Ratio


Amcad Biomed PS Ratio Historical Data

The historical data trend for Amcad Biomed's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amcad Biomed PS Ratio Chart

Amcad Biomed Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.05 12.00 13.77 21.30 24.29

Amcad Biomed Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.30 25.14 23.18 21.60 24.29

Competitive Comparison of Amcad Biomed's PS Ratio

For the Medical Devices subindustry, Amcad Biomed's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amcad Biomed's PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Amcad Biomed's PS Ratio distribution charts can be found below:

* The bar in red indicates where Amcad Biomed's PS Ratio falls into.


;
;

Amcad Biomed PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Amcad Biomed's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=13.45/0.907
=14.83

Amcad Biomed's Share Price of today is NT$13.45.
Amcad Biomed's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.91.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Amcad Biomed  (ROCO:4188) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Amcad Biomed PS Ratio Related Terms

Thank you for viewing the detailed overview of Amcad Biomed's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Amcad Biomed Business Description

Traded in Other Exchanges
N/A
Address
No. 167, Fuxing North Road, 5th Floor, Zhongshan District, Taipei, TWN, 104
Amcad Biomed Corp develops computer-aided detection and diagnosis(CADe/CADx) software devices. Its product pipeline includes AmCAD-UT Detection, AmCAD-UV, AmCAD and AmCAD-UO. The company's geographical segments include Taiwan, China, and other countries, out of which the majority of the revenue is generated from Europe. The company has two segments: Medical diagnostic software: which is responsible for the development and sales of smart medical imaging diagnostic software device and Precision medical equipment: which is responsible for research, development, manufacturing and sales of high-end ultrasonic probes.

Amcad Biomed Headlines

No Headlines